Hospital
American Oncologic Hospital
American Oncologic Hospital was paid $1.50M by Medicaid between Apr 2019 and Dec 2024, across 94 billing codes. Its largest line is 77386, — 20% of everything it billed.
33Billing provider infoAMERICAN ONCOLOGIC HOSPITAL
PHILADELPHIA, PA 19111
PHILADELPHIA, PA 19111
33aNPI1730195017assigned 07/31/2006
33bProvider typeSpecial Hospital
28Total paid$1.50M
24GClaims32,599
24DCodes billed94
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers
Next to other Special Hospital providers in Pennsylvania
Rank by total paid#4 of 7
Median peer was paid$1.50M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,471 | $17K | |
| 2020 | 4,775 | $137K | |
| 2021 | 13,876 | $916K | |
| 2022 | 1,491 | $76K | |
| 2023 | 5,220 | $176K | |
| 2024incomplete | 5,766 | $174K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 77386 | 20% | 915 | 83 | $300K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 15% | 238 | 228 | $222K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 9.8% | 1,655 | 1,607 | $146K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 7.2% | 1,286 | 1,272 | $108K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.5% | 343 | 339 | $82K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 426 | 182 | $38K |
| 11102 | 2.5% | 174 | 169 | $38K | |
| 76642 | 2.5% | 694 | 629 | $37K | |
| 77412 | 2.2% | 708 | 89 | $33K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.2% | 222 | 90 | $33K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 482 | 439 | $32K |
| 74183 | 1.8% | 68 | 67 | $27K |
82 more codes
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.8% | 250 | $26K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 586 | $25K |
| 77336 | 1.6% | 569 | $25K | |
| 77334 | 1.6% | 262 | $24K | |
| 71250 | 1.6% | 358 | $24K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.5% | 344 | $22K |
| 77066 | Tomosynthesis, mammo | 1.4% | 232 | $22K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.4% | 406 | $20K |
| 77065 | Tomosynthesis, mammo | 1.3% | 294 | $20K |
| 80053 | Comprehensive metabolic panel | 1.2% | 2,904 | $19K |
| 76376 | 1.0% | 936 | $16K | |
| 72197 | <1% | 40 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 220 | $13K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 55 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,172 | $12K |
| 17311 | <1% | 40 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,111 | $10K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 30 | $10K |
| 88341 | <1% | 97 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 328 | $6K |
| 77300 | <1% | 61 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 268 | $4K |
| 88342 | <1% | 166 | $4K | |
| 88313 | <1% | 107 | $4K | |
| 78306 | <1% | 60 | $4K | |
| 86304 | <1% | 107 | $3K | |
| 77062 | <1% | 94 | $3K | |
| 96367 | <1% | 224 | $3K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 125 | $3K |
| 88112 | <1% | 147 | $3K | |
| 83735 | <1% | 448 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 325 | $2K |
| 74178 | <1% | 12 | $2K | |
| 77280 | <1% | 62 | $2K | |
| 70491 | <1% | 12 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 32 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $1K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 70 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 24 | $1K |
| 76536 | <1% | 27 | $1K | |
| 36591 | <1% | 110 | $1K | |
| 88360 | <1% | 26 | $1K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 510 | $1K |
| 88173 | <1% | 25 | $969.96 | |
| 82565 | <1% | 235 | $899.98 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 153 | $890.69 |
| 84100 | <1% | 220 | $866.99 | |
| 88142 | <1% | 52 | $683.64 | |
| 83615 | <1% | 108 | $607.52 | |
| 77061 | <1% | 25 | $540.24 | |
| 52000 | <1% | 12 | $450.23 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 159 | $425.44 |
| 99153 | Mod sedat endo service >5yrs | <1% | 68 | $394.58 |
| 94729 | <1% | 14 | $390.15 | |
| 99152 | <1% | 68 | $373.14 | |
| 94726 | <1% | 13 | $357.43 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 994 | $231.56 |
| 88312 | <1% | 26 | $212.20 | |
| 88307 | <1% | 25 | $204.74 | |
| 78999 | <1% | 15 | $184.13 | |
| 85610 | <1% | 87 | $178.81 | |
| 96402 | <1% | 15 | $170.10 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,250 | $169.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,351 | $125.13 |
| 94010 | <1% | 12 | $122.24 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,256 | $85.35 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 868 | $72.47 |
| 82948 | <1% | 45 | $72.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $58.63 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 317 | $48.41 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,071 | $29.76 |
| 86850 | <1% | 17 | $12.33 | |
| 86901 | <1% | 17 | $6.08 | |
| 86900 | <1% | 17 | $6.01 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $0.02 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 62 | $0.00 |
| A9270 | Non-covered item or service | 0% | 28 | $0.00 |
| 82378 | 0% | 14 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 136 | $0.00 |
| J3490 | Unclassified drugs | 0% | 278 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 27 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATCHETT, JARRED (CFO)